Skip to content

Prospective registry study of mechanical thrombectomy versus optimal medical treatment for acute anterior circulation large-core ischemic stroke

Prospective registry study of mechanical thrombectomy versus optimal medical treatment for acute anterior circulation large-core ischemic stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600129142
Enrollment
Unknown
Registered
2026-07-31
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute anterior circulation large-core ischemic stroke (ASPECTS 0-5 or core infarct volume > 50ml)

Interventions

Mechanical thrombectomy group:None
standard medical treatment group:None

Sponsors

Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >=18 years old; 2.Patients with acute ischemic stroke with onset within 24 hours from the last normal time received endovascular therapy or optimal medical therapy; 3.The presence of occlusion of internal carotid artery or M1 / M2 segment of middle cerebral artery was confirmed by CT angiography, magnetic resonance angiography or digital subtraction angiography; 4.A baseline ASPECTS score of 0-5 or a large cerebral infarct core volume >= 50ml (defined as relative cerebral blood flow < 30% on CT perfusion imaging) was assessed on the basis of noncontrast CT (NCCT); 5.Informed consent was obtained.

Exclusion criteria

Exclusion criteria: 1.Acute intracranial hemorrhage was confirmed by CT or MRI. 2.Baseline imaging examination showed that there was mass effect, accompanied by ventricular compression, midline shift, or cerebral herniation. 3.Pregnant or childbearing age women, urine or serum ß-human chorionic gonadotropin test may be positive; 4.Severe bleeding tendency, severe heart, liver or kidney disease, or sepsis; 5.Terminal illness with life expectancy less than 6 months.

Design outcomes

Primary

MeasureTime frame
Distribution of 90-day mRS;

Secondary

MeasureTime frame
90-day mRS 0-3;death at 90 days;Symptomatic intracerebral hemorrhage;

Countries

China

Contacts

Public ContactGuangdong Lu

The First Affiliated Hospital with Nanjing Medical University

canhetingyu1989@163.com+86 25 68306068

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026